UPMC Hillman Cancer Center ASTRO 2023 Presentations

1:22 – 1:42 p.m.
Non Definitive Lung Options: Palliation and XRT Alone
Location: Room 33
Uzoma Iheagwara, MD, PhD – UPMC Hillman Cancer Center

Sunday, October 1 

8 – 9 a.m.
SS 02 – GYN 1: Integrating the Next Wave of Biomarkers for Future Gynecologic Clinical Trials
CE: 1.00
Location: Room 5
Parul Barry, MD – UPMC Radiation Oncology; Andrew McDonald, MD, MS – University of Alabama Birmingham School of Medicine

Monday, October 2

9:15 – 9:25 a.m.
Conformality Indices and Brain Dose Objective for Multi-Lesion Brain Single Isocenter Linac-Based Stereotactic Radiosurgery
Shada Wadi-Ramahi, PhD – University of Pittsburgh, UPMC Hillman Cancer Center

10:45 a.m. – 12 p.m.
International 04 – International Radiation Oncology Training and Educational Opportunities
CE: 1.25
Location: Room 5
Tamer Abdelrhman, MD, PhD, MS – Loyola University Chicago; Surbhi Grover, MD, MPH – University of Pennsylvania Health System; Shada Wadi-Ramahi, PhD – University of Pittsburgh, UPMC Hillman Cancer Center

11:02 – 11:08 a.m.
Practice Building Logistics 
Location: Room 31
Uzoma Iheagwara, MD, PhD – UPMC Hillman Cancer Center

11:11 – 11:23 a.m.
AAPM International Education Program
Location: Room 5
Shada Wadi-Ramahi, PhD – University of Pittsburgh, UPMC Hillman Cancer Center

11:17 – 11:32 a.m. Treatment Planning – The Physicist and Physician Team 
Location: Room 29
Hayeon Kim, PhD – UPMC Magee-Womens Hospital and UPMC Hillman Cancer Center

5 – 6 p.m.
Combination Immunotherapy with Partial Tumor Radiotherapy is Inferior to Whole Tumor Radiotherapy in Preclinical Melanoma Tumors 
Location: Hall B2
Sean Koerner, MD, MS – UPMC Hillman Cancer Center, Department of Radiation Oncology

5 – 6 p.m.
Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity
Location: Hall B2
Mohamed Elfayoumi, BS – University of Pittsburgh, UPMC Hillman Cancer Center

Tuesday, October 3 

8:02 – 8:14 a.m.
Financial Toxicity Among Survivors of Head and Neck Cancer: The Lasting Costs of Cure and Managing Treatment-Related Toxicities
Location: Room 31
Yvonne Mowery, MD, PhD, BS – University of Pittsburgh, UPMC Hillman Cancer Center

2:30 – 3:45 p.m.
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published
SBRT Data
Location: Hall B2
Mohammed Mohammed, MD – UPMC Hillman Cancer Center

2:30 – 3:45 p.m.
Long-Term Urinary Toxicity Follow-Up of Combined External Beam Radiation and Cs-131 LDR Brachytherapy Boost for
Prostate Cancer
Location: Hall B2
Mohamed Abdelhakiem, MD – UPMC Hillman Cancer Center

2:30 – 3:45 p.m.
SS 24 – Bio 5: Immunotherapy and Immune Response
CE: 1.25
Location: Room 2
Yvonne Mowery, MD, PhD, BS – University of Pittsburgh, UPMC Hillman Cancer Center; Silvia Chiara Formenti, MD, FASTRO – Weill Cornell Medical College

4 – 5 p.m.
Panel 18 – ASTRO/ADROP Joint Session – Employing Equity in Residency Recruitment and Cultivating a Culture of Inclusion
CE: 1.00
Location: Room 32
Parul Barry, MD – UPMC Radiation Oncology

5:15 – 6:15 p.m.
Impact of Race and Socioeconomic Factors on Clinical Outcomes in Cervical and Endometrial Cancer Patients Treated
with Brachytherapy 
Location: Hall B2
Ria Mulherkar, MD – UPMC Hillman Cancer Center

5:15 – 6:15 p.m.
Intraoral Gavage of Second Generation Probiotic Lactobacillus Reuteri Releasing IFN-ß (LR-IFN-ß) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiati 
Location: Hall B2
Diala Hamade, MD – UPMC 

5:15 – 6:15 p.m.
Is Programmed Death Ligand 1(PD-L1) Expression in Vulvar Cancer Prognostic for Locoregional Control? 
Location: Hall B2
Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center

5:15 – 6:15 p.m.
QP 16 – H&N 3: Innovative Approaches to Individualizing Therapy for Head & Neck and Skin Cancer
CE: 1.00
Location: Room 4
Christopher Wilke, MD, PhD – UPMC Hillman Cancer Center; Nikhil Joshi, MD – Rush University Medical Center